General Announcement::Glenmark receives ANDA approval for Fluocinolone Acetonide Topical Oil, 0.01% (Body Oil)

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
26-Oct-2018 12:45:03
Status
New
Announcement Sub Title
Glenmark receives ANDA approval for Fluocinolone Acetonide Topical Oil, 0.01% (Body Oil)
Announcement Reference
SG181026OTHRXCXQ
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
26/10/2018 10:00:00
Description (Please provide a detailed description of the event in the box below)
Sub: Glenmark Pharmaceuticals receives ANDA approval for Fluocinolone Acetonide Topical Oil,
0.01% (Body Oil).

With reference to the subject mentioned above, kindly find attached media release which is self-explanatory.

Request you to kindly take the same on record.

Attachments

Covering.pdf
Total size =269K